One thought on “Merck has expanded the scope of its voluntary partial recall to an additional ten lots of VAXNEUVANCE<sup>®</sup> (Pneumococcal 15-valent Conjugate Vaccine). Please click here for more information.”
Comments are closed.
This section contains information intended for health care professionals in the United States only and is not intended for the general public.
This site is intended only for residents of the United States, its territories, and Puerto Rico. Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
All rights reserved. US-STE-00262 03/19
Comments are closed.
You are about to leave MerckVaccines.com
The user sumityadavacc created the working draft for this post.